Development of a scale to predict decline in patients with mild Alzheimer's disease

Journal of the American Geriatrics Society

Volumn 51, Issue 1, 2003, Pages 91-95

  Santillan, Concepcion E ^a,b,c   Fritsch, Thomas ^a,b   Geldmacher, David S ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University Memory and Aging Center   (United States)

Author keywords

Alzheimer's disease; Progression; Scale

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NEUROPSYCHOLOGICAL TEST; PREDICTION AND FORECASTING; PSYCHOSIS; QUALITY OF LIFE; RATING SCALE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 0037239425     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1601-5215.2002.51016.x     Document Type: Article

References (30)

1. Hughes CP, Berg L, Danziger WL et al. A new clinical scale for staging of dementia. Br J Psychiatry 1982;140:566-572.
2. Berg L. Clinical dementia rating (CDR). Psychopharmacol Bull 1988;24:637-639.
3. Berg L, Miller JP, Storandt M. Mild senile dementia of the Alzheimer Type 2. Longitudinal assessment. Ann Neurol 1988;23:477-484.
4. Mortimer J, Ebbitt B, June S et al. Predictors of cognitive and functional progression in patients with probable Alzheimer's disease. Neurology 1992;42:1689-1696.
5. Stern RG, Mohs RC, Davidson M et al. A longitudinal study of Alzheimer's disease: Measurement, rate and predictors of cognitive deterioration. Am J Psychiatry 1994;151:390-396.
6. Esteban-Santillan CG, Geldmacher DS, Cole R. The clinical dementia rating in mild Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1997;9:173.
7. Geldmacher D, Santillan CG, Fritsch T. Development of a scale to predict decline among mildly demented Alzheimer disease patients. Neurobiol Aging 2000;21(Suppl. 1S):S93.
8. Morris JC, Heyman A, Mohs RC et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Neurology 1989;39:1159-1165.
9. Tariot PN, Mack JL, Patterson MB et al. The CERAD behavior rating scale for dementia. Am J Psychiatry 1995;152:1349-1357.
10. Reisberg B, Borenstein J, Salob SP et al. Behavioral symptoms in Alzheimer's disease. Phenomenology and treatment. J Clin Psychiatry 1987;48(Suppl.):9-15.
11. Blessed G, Tomlimson BE, Roth M. The association between quantitative measures of dementia and senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797-811.
12. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
13. Hachinski VC, Illiff LD, Zihlka EZ et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-637.
14. Burke WJ, Miller JP, Rubin E et al. Reliability of the Washington University clinical dementia rating (CDR). Arch Neurol 1988;45:31-32.
15. Morris JC, Ernesto C, Schafer K et al. Clinical dementia rating training and reliability in multi-center studies: The Alzheimer disease cooperative study experience. Neurology June, 1997;48:1508-1510.
16. Morris JC, McKee DW Jr, Storandt M et al. Very mild Alzheimer's disease: Informant-based clinical psychometric, and pathologic distinction from normal aging. Neurology 1991;41:469-478.
17. Telleria-Diaz JA, Rosello-Silva H, Gomez-Viera N. A longitudinal study of the course of the Alzheimer type dementia. Rev Neurol 1997;25:1551-1556.
18. Berg L, Danziger WL, Storandt M et al. Predictive features in mild senile dementia of the Alzheimer type. Neurology 1984;34:563-569.
19. Rasmusson DX, Carson KA, Kawas C et al. Predicting rate of cognitive decline in probable Alzheimer's disease. Brain Cogn 1996;31:133-147.
20. Stern Y, Alexander GE, Prohovnik I et al. Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease. Ann Neurol 1992;32:371-375.
21. Gormley N, Rizwan MR. Prevalence and clinical correlates of psychotic symptoms in Alzheimer's disease. Int J Geriatr Psychiatry 1998;13: 410-414.
22. Lopez OL, Wisniewski SR, Becker JT et al. Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease. Arch Neurol 1999;56:1266-1272.
23. Hirono N, Mori E, Yasuda M et al. Factors associated with psychotic symptoms in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1998;64:648-652.
24. Stern Y, Albert M, Brandt J et al. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: Prospective analysis from the Predictors Study. Neurology 1994;44:2300-2307.
25. Stern Y, Hesdorffer D, Sano M et al. Measurement and prediction of functional capacity in Alzheimer's disease. Neurology 1990;40:8-14.
26. Starkstein SE, Chemerinski E, Sabe L et al. Prospective longitudinal study of depression and anosognosia in Alzheimer's disease. Br J Psychiatry 1997;171:47-52.
27. Vasterling JJ, Seltzer B, Watrous WE. Longitudinal assessment of deficit unawareness in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol 1997;10:197-202.
28. Galasko D, Edland SD, Morris JC et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years. Neurology 1995;45:1451-1455.
29. Binetti G, Magni E, Padovani A et al. Executive dysfunction in early Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996;60:91-93.
30. Perry RJ, Hodges JR. Attention and executive deficits in Alzheimer's disease. A critical review. Brain 1999;122:383-404.